Competing endogenous RNAs network and therapeutic implications: New horizons in disease research
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · 2025-03 · 1868 (1) · 195073
DOI: 10.1016/j.bbagrm.2024.195073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2025-03. Verfasst von Nahla E El-Ashmawy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Pharmacy, Tanta University, 31527, Egypt; Department of Pharmacology and Biochemistry, Faculty of Pharmacy, The B…. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Untranslated, Gene Regulatory Networks, RNA, Long Noncoding. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 108 Literaturangaben.
Abstract (Originalsprache)
Different diseases may arise from the dysregulation of non-coding RNAs (ncRNAs), which regulation is necessary for maintaining cellular homeostasis. ncRNAs are regulated by transcriptional, post-transcriptional, translational and post-translational processes. Post-transcriptional regulation of gene expression is carried out by microRNAs (miRNAs), a class of small ncRNA molecules, which can identify their target sites by a brief nucleotide sequence, known as the miRNA response element (MRE), present on the miRNA seed sequence and the target transcript. This binding between miRNAs and targets can regulate the gene expression through inhibition of translation or degradation of target messenger RNA (mRNA). The transcripts that share MREs can be involved in competition for the central miRNA pool, which could have an indirect impact on each other's regulation. This competition network is called competing endogenous RNAs network (ceRNET). Many ncRNAs, including circular RNA, pseudogene, and long non-coding RNA, as well as mRNA, a coding RNA transcript, make up ceRNET. These components play a crucial role in post-transcriptional regulation and are involved in the diagnosis and treatment of many pathological disorders. The mechanism of ceRNET and its essential components, as well as their therapeutic implications in different diseases such as cancer, diabetes mellitus, neurological, cardiovascular, hepatic and respiratory disorders were covered in this review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, Faculty of Pharmacy, Tanta University, 31527, Egypt; Department of Pharmacology and Biochemistry, Faculty of Pharmacy, The British University in Egypt, El Sherouk City, Cairo 11837, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Tanta University, 31527, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Tanta University, 31527, Egypt. Electronic address: amera.ibrahim@pharm.tanta.edu.eg.
Zitieren
APA
El-Ashmawy, N. E., Khedr, E. G., Darwish, R. T., & Ibrahim, A. O. (2025). Competing endogenous RNAs network and therapeutic implications: New horizons in disease research. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1868(1), 195073. https://doi.org/10.1016/j.bbagrm.2024.195073
Vancouver
El-Ashmawy NE, Khedr EG, Darwish RT, Ibrahim AO. Competing endogenous RNAs network and therapeutic implications: New horizons in disease research. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2025;1868(1):195073. doi:10.1016/j.bbagrm.2024.195073
BibTeX
@article{ElAshmawy2025,
author = {El-Ashmawy, Nahla E and Khedr, Eman G and Darwish, Renad T and Ibrahim, Amera O},
title = {Competing endogenous RNAs network and therapeutic implications: New horizons in disease research},
journal = {Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms},
year = {2025},
volume = {1868},
number = {1},
pages = {195073},
doi = {10.1016/j.bbagrm.2024.195073}
}
EUVIMED